Literature DB >> 10930060

Dimethylacetamide, ethylenediamine, and diphenylmethane diisocyanate poisoning manifest as acute psychosis and pulmonary edema: treatment with hemoperfusion.

T C Su1, P H Lin, M J Chiu, T S Chu, M J Chang, J D Wang, T J Cheng.   

Abstract

CASE REPORT: A 27-year-old man, employed by a synthetic fiber company, had been exposed to dimethylacetamide, ethylenediamine, and diphenylmethane diisocyanate in a confined space continuously for 4-6 hours per day for 3 days before admission. Hallucinations and delusions were noted at admission; pulmonary edema developed subsequently. The electroencephalogram showed diffuse moderate cortical dysfunction and slow waves at 4-7 Hz, 20-80 microV. Seizures, liver injury, and rhabdomyolysis were noted on the 4th hospital day. The patient was treated by hemoperfusion with a decrease in urine dimethylacetamide from 3,265 mg/g to 4 mg/g creatinine over 4 days. Serial urinary dimethylacetamide and electroencephalogram correlated with the clinical condition.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10930060     DOI: 10.1081/clt-100100953

Source DB:  PubMed          Journal:  J Toxicol Clin Toxicol        ISSN: 0731-3810


  3 in total

1.  Incidence of dimethylacetamide induced hepatic injury among new employees in a cohort of elastane fibre workers.

Authors:  C-Y Lee; S-J Jung; S-A Kim; K-S Park; B-G Ha
Journal:  Occup Environ Med       Date:  2006-05-25       Impact factor: 4.402

Review 2.  Toxic hepatitis in occupational exposure to solvents.

Authors:  Giulia Malaguarnera; Emanuela Cataudella; Maria Giordano; Giuseppe Nunnari; Giuseppe Chisari; Mariano Malaguarnera
Journal:  World J Gastroenterol       Date:  2012-06-14       Impact factor: 5.742

3.  TNF-α and IL-6 as Biomarkers of Impaired Lung Functions in Dimethylacetamide Exposure.

Authors:  Lütfiye Tutkun; Servet Birgin İritaş; Serdar Deniz; Özgür Öztan; Sedat Abuşoğlu; Ali Ünlü; Vugar Ali Türksoy; Sultan Pınar Çetintepe
Journal:  J Med Biochem       Date:  2019-05-11       Impact factor: 3.402

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.